scholarly journals Kaempferol and Its Glycoside Derivatives as Modulators of Etoposide Activity in HL-60 Cells

2021 ◽  
Vol 22 (7) ◽  
pp. 3520
Author(s):  
Magdalena Kluska ◽  
Michał Juszczak ◽  
Jerzy Żuchowski ◽  
Anna Stochmal ◽  
Katarzyna Woźniak
Keyword(s):  
Cell Cycle ◽  
Free Radicals ◽  
Lens Culinaris ◽  
Cell Cycle Progression ◽  
Opposite Effect ◽  
Promyelocytic Leukemia ◽  
Cycle Progression ◽  
Aerial Parts ◽  
Proliferation And Apoptosis ◽  
Antitumor Properties

Kaempferol is a polyphenol found in a variety of plants. Kaempferol exerts antitumor properties by affecting proliferation and apoptosis of cancer cells. We investigated whether kaempferol and its glycoside derivatives—kaempferol 3-O-[(6-O-E-caffeoyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside (P2), kaempferol 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside (P5) and kaempferol 3-O-[(6-O-E-feruloyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside (P7), isolated from aerial parts of Lens culinaris Medik.—affect the antitumor activity of etoposide in human promyelocytic leukemia (HL-60) cells. We analyzed the effect of kaempferol and its derivatives on cytotoxicity, DNA damage, apoptosis, cell cycle progression and free radicals induced by etoposide. We demonstrated that kaempferol increases the sensitivity of HL-60 cells to etoposide but does not affect apoptosis induced by this drug. Kaempferol also reduces the level of free radicals generated by etoposide. Unlike kaempferol, some of its derivatives reduce the apoptosis of HL-60 cells (P2 and P7) and increase the level of free radicals (P2 and P5) induced by etoposide. Our results indicate that kaempferol and its glycoside derivatives can modulate the activity of etoposide in HL-60 cells and affect its antitumor efficacy in this way. Kaempferol derivatives may have the opposite effect on the action of etoposide in HL-60 cells compared to kaempferol.

scholarly journals Kaempferol and Its Glycoside Derivatives as Modulators of Etoposide Activity in HL-60 Cells

2021 ◽  
Author(s):  
Magdalena Kluska ◽  
Michał Juszczak ◽  
Jerzy Żuchowski ◽  
Anna Stochmal ◽  
Katarzyna Woźniak
Keyword(s):  
Cell Cycle ◽  
Free Radicals ◽  
Lens Culinaris ◽  
Cell Cycle Progression ◽  
Opposite Effect ◽  
Cycle Progression ◽  
Aerial Parts ◽  
Proliferation And Apoptosis ◽  
Antitumor Properties ◽  
The Impact

Abstract Kaempferol is a polyphenol found in a variety of plants. Kaempferol has antitumor properties by affecting proliferation and apoptosis of cancer cells. We investigated whether kaempferol and its glycoside derivatives: kaempferol 3-O-[(6-O-E-caffeoyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D -glucuropyranoside (P2), kaempferol 3-O-[(6-O-E-p-coumaroyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside (P5) and kaempferol 3-O-[(6-O-E-feruloyl)-β-D-glucopyranosyl-(1→2)]-β-D-galactopyranoside-7-O-β-D-glucuropyranoside (P7) isolated from aerial parts of Lens culinaris Medik. affect the antitumor activity of etoposide in HL-60 cells. We analyzed the effect of kaempferol and its derivatives on cytotoxicity, DNA damage, apoptosis, cell cycle progression and free radicals induced by etoposide. We also studied the impact of kaempferol and its derivatives on the expression of HO-1 and Nrf-2 genes in HL-60 cells. We demonstrated that kaempferol increases the sensitivity of HL-60 cells to etoposide but does not affect apoptosis induced by this drug. Kaempferol also reduces the level of free radicals generated by etoposide. Unlike kaempferol, some of its derivatives reduce the apoptosis of HL-60 cells (P2 and P7) and increase the level of free radicals (P2 and P5) induced by etoposide. Our results indicate that kaempferol derivatives may have an opposite effect on the action of etoposide in HL-60 cells compared to kaempferol.

scholarly journals MiR-15b Targets Cyclin D1 to Regulate Proliferation and Apoptosis in Glioma Cells

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Guan Sun ◽  
Lei Shi ◽  
Shushan Yan ◽  
Zhengqiang Wan ◽  
Nan Jiang ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Cyclin D1 ◽  
Cell Cycle Progression ◽  
Therapeutic Strategy ◽  
Glioma Cells ◽  
Luciferase Assay ◽  
Luciferase Reporter ◽  
Cycle Progression ◽  
Cycle Arrest ◽  
Proliferation And Apoptosis

Aim. To investigate the role and mechanism of miR-15b in the proliferation and apoptosis of glioma.Methods. The miR-15b mimics were transfected into human glioma cells to upregulate the miR-15b expression. Cyclin D1 was determined by both western blotting analysis and luciferase reporter assay. Methylthiazol tetrazolium (MTT) and flow cytometry were employed to detect the cell proliferation, cell cycle, and apoptosis.Results. Overexpression of miR-15b inhibits proliferation by arrested cell cycle progression and induces apoptosis, possibly by directly targeting Cyclin D1. Both luciferase assay and bioinformatics search revealed a putative target site of miR-15b binding to the 3′-UTR of Cyclin D1. Moreover, expression of miR-15b in glioma tissues was found to be inversely correlated with Cyclin D1 expression. Enforced Cyclin D1 could abrogate the miR-15b-mediated cell cycle arrest and apoptosis.Conclusions. Our findings identified that miR-15b may function as a glioma suppressor by targeting the Cyclin D1, which may provide a novel therapeutic strategy for treatment of glioma.

Proteomic Analysis of Acute Promyelocytic Leukemia Reveals That PML-RARalpha Induces Cell Cycle Progression and Mitotic Exit by Increased Expression and Decreased Ser63 Phosphorylation of OP18.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 2028-2028
Author(s):  
A. PeerZada ◽  
M. Geletu ◽  
J. Pullikan ◽  
V. Reddy ◽  
W. Hiddemann ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Acute Promyelocytic Leukemia ◽  
Cell Cycle Progression ◽  
Promyelocytic Leukemia ◽  
Mitotic Exit ◽  
Cycle Progression ◽  
2D Gel ◽  
First Time ◽  
Common Cell

Abstract We applied a mass spectrometry based approach to explore the proteins differentially regulated by PML-RARalpha, a translocation characteristic of acute promyelocytic leukemia (APL). Bioinformatic pathway analysis placed the 46 identified PML-RARalpha regulated proteins into three major networks, OP18-MAPK1, HSP-STAT3 and CCT-MYC. Using this approach, we were able to generate a common cell cycle network of the proteins in these pathways. Further analysis indicated that mRNA expression of OP18, which belonged to this network, was elevated in APL patients and the increased OP18 protein expression upon PML-RARalpha induction was overcome by retinoic acid treatment. Here we also report, for the first time a novel role of PML-RARalpha in cell cycle progression and mitotic exit. RNA interference experiments revealed that siRNA against OP18 overcomes PML-RARalpha effects on cell cycle progression. In addition to increased OP18 expression by PML-RARalpha, 2D gel electrophoresis revealed an isomer of OP18, subsequently confirmed by 2D-western as ser63 phosphomer to be downregulated by PML-RARalpha. Based on these findings, point mutation experiments indicated that decreased phosphorylation of ser63 in OP18 is important for PML-RARalpha mediated cell cycle and mitotic index effects since a constitutive phosphorylated mutant (ser63/asp) of OP18 overcame the PML-RARalpha effects in U9/PR cells, NB4 and APL patients. In summary, our results demonstrate that the effect of PML-RARalpha on cell cycle progression and mitotic exit is via two mechanisms: increasing the expression of OP18 and decreasing the phosphorylation of OP18 at ser63.

The Fluctuation of Telomere Repeat Binding Factor 1 during Cell Cycle and Its Localization in Telomerase-Positive and Negative Cells.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4326-4326
Author(s):  
Jianping Lan ◽  
He Huang ◽  
Yuanyuan Zhu ◽  
Jie Sun
Keyword(s):  
Cell Cycle ◽  
Telomere Length ◽  
Hela Cells ◽  
Cell Cycle Progression ◽  
Promyelocytic Leukemia ◽  
Final Concentration ◽  
Cycle Progression ◽  
Telomere Repeat ◽  
Binding Factor ◽  
M Phase

Abstract Telomere is a nucleoprotein complex which caps the extreme ends of eukaryotic chromosomes. In human, telomere is composed of a tandem repeat array of TTAGGG hexanucleotide and bound to a set of specific proteins. These proteins function to maintain the integrity of chromosomes and genomic stability. Among these proteins, telomere repeat binding factor 1(TRF1) is the first telomere binding protein which was isolated by DNA affinity chromatography in 1995. TRF1 serves as a negative regulator of telomere length since TRF1 overexpression would elicit the shortening of telomere length in telomerase-positive cells. Meanwhile, overexpression of TRF1 would also induce the entry into mitosis and increase mitotic cells. These observation indicated TRF1 might participate in cell cycle regulation. However, the underlying mechanism in which TRF1 regulates the cell cycle and the endogenous level of TRF1 were not well-documented during cell cycle progression. To address these questions, we arrested HeLa cells at different phases by a combination of thymidine(5mM at final concentration) and nocodazole(20mM at final concentration) and detected the TRF1 levels by semi-quantitive Western Blotting assay. Cell cycle was verified by flow cytometry. Our results showed TRF1 level fluctuated coincided with cell cycle progression which reached the zenith at the M phase and went down to the nadir at G1/S point. Densitometry analysis demonstrated that the level of TRF1 at M phase was 3.9 times more than that at G1/S point(n=3, p<0.01). These results suggested that TRF1 might be essential for proper cell cycle progression and it was likely to take part in regulation of cell cycle chechpoint. TRF1 is also expressed in telomerase-negative cells. To further discriminate the different functions of TRF1 and decipher its protein-protein interaction network in telomerase-positive and negative cells, full-length TRF1 cDNA was amplified by PCR and subsequently subcloned into pEGFP-C2 vector to express TRF1 tagged by enhanced green fluorescent protein. This construct was then transiently transfected into telomerase-negative cells(WI38-2RA) and telomerase-positive cells(HeLa). Immunoflourescent staining was employed to check the localization of TRF1 in these two kinds of cells. Although in both cells, TRF1 was distributed in a speckled pattern in the nuclei, TRF1 did exclusively colocalize with promyelocytic leukemia(PML) nuclear body in WI38-2RA cells but not in HeLa cells. PML fused with RARα due to chromosome15,17 translocation which led to disassembly of PML nucleur body in acute promyelocytic leukemia. These preliminary results suggested that TRF1 might have the different regulating mechanism and interacting network.

scholarly journals LncRNA EPIC1 Promotes Cancer Cell Proliferation and Inhibits Apoptosis in Gallbladder Cancer Interacting with lncRNA LET

2020 ◽  
Author(s):  
Changbo Fu ◽  
Lei Nie ◽  
Tao Yin ◽  
Xuan Xu ◽  
weijun lu
Keyword(s):  
Cell Cycle ◽  
Cell Proliferation ◽  
Gallbladder Cancer ◽  
Cancer Cell ◽  
Cell Cycle Progression ◽  
Human Cancer ◽  
Cancer Cell Proliferation ◽  
Cycle Progression ◽  
Tumor Tissues ◽  
Proliferation And Apoptosis

Abstract Background: LncRNA EPIC1 is likely involved in human cancer by promoting cell cycle progression. Our study was carried out to investigate the involvement of EPIC1 in gallbladder cancer (GBC). Methods: Expression levels of EPIC1 in two types of tissues (GBC and paracancerous) and plasma were measured by performing qPCR. GBC-SD and SGC-996 cells were transfected with LET and EPIC1 expression vectors.Results: In the preset study we found that EPIC1 was upregulated in tumor tissues than in paracancerous tissues of GBC patients, and plasma levels of EPIC1 were significantly correlated with levels of EPIC1 in tumor tissues. LncRNA LET was downregulated in tumor tissues than in paracancerous tissues and was inversely correlated with EPIC1 in both tumor tissues and paracancerous tissues. Overexpression of EPIC1 led to downregulated LET, and LET overexpression also mediated the downregulation of EPIC1. EPIC1 led to accelerated GBC cell proliferation and inhibited apoptosis. Overexpression of LET played opposites roles. In addition, overexpression of LET also attenuated the effects of EPIC1 overexpression on cancer cell proliferation and apoptosis. Conclusion: Therefore, therefore, lncRNA EPIC1 may promote cancer cell proliferation and inhibit apoptosis in GBC by interacting with LET.

scholarly journals Paradoxical Enhancement of Leukemogenesis in Acute Myeloid Leukemia Cells with Moderately Attenuated RUNX1 Expressions

Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 2710-2710
Author(s):  
Kensho Suzuki ◽  
Ken Morita ◽  
Shintaro Maeda ◽  
Hiroki Kiyose ◽  
Souichi Adachi ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Acute Myeloid Leukemia ◽  
Free Radicals ◽  
Protein Level ◽  
Myeloid Leukemia ◽  
Cell Cycle Progression ◽  
Leukemia Cells ◽  
Cycle Progression ◽  
Runx1 Expression ◽  
Acute Myeloid

Abstract Although Runt-related transcription factor 1 (RUNX1), a member of RUNX transcription family, is known for its oncogenic role in the development of acute myeloid leukemia (AML), evidence from other groups support the oncosuppressive property of RUNX1 in leukemia cells, casting a question over the bidirectional function of RUNX1 and it is currently highly controversial. Here we report that the dual function of RUNX1 possibly arise from the total level of RUNX family expressions. To examine the precise mechanism of RUNX1 expression in leukemogenesis, we first prepared several tetracycline-inducible short hairpin RNAs (shRNAs) which could attenuate the expressions of RUNX1 at different levels in AML cells (MV4-11 and MOLM-13 cells). Intriguingly, while AML cells transduced with shRNAs which could down-regulate RUNX1 expression below 10% at protein level (sh_Rx1_profound) deteriorated the proliferation speed of AML cells, AML cells transduced with shRNAs which could moderately down-regulate RUNX1 expression to 70% at protein level (sh_Rx1_moderate) paradoxically promoted the cell cycle progression and doubled the growth rate of AML cells. Besides, RUNX1-moderately expressing AML patient cohort exhibited the worse outcome compared to RUNX1-high or RUNX1-low expressing cohorts (n = 187), indicating an underlying mechanism that confer growth advantage to AML cells with moderately inhibited RUNX1 expressions. To further investigate the correspondent gene in this paradoxical enhancement of oncogenesis in sh_Rx1_moderate-transduced AML cells, we performed comprehensive gene expression array and extracted genes that are highly up-regulated in RUNX1 moderate inhibition and down-regulated in AML cells transduced with sh_Rx1_profound. We hereafter focused on the top-listed gene glutathione S-transferase alpha 2 (GSTA2) and addressed the interaction of RUNX1 and GSTA2 and their functions in AML cells. Real time quantitative PCR (RT-qPCR) and immunoblotting revealed that the expression of GSTA2 was actually up-regulated in sh_Rx1_moderate-transduced AML cells and down-regulated in AML cells transduced with sh_Rx1_profound. Interestingly, equivalent level of compensatory up-regulation of RUNX2 and RUNX3 were observed in sh_Rx1_moderate- and sh_Rx1_profound-transduced AML cells, creating an absolute gap in the expression of total amount of RUNX (RUNX1 + RUNX2 + RUNX3), which was confirmed by RT-qPCR (total amount of RUNX expressions were estimated by primers amplifying the specific sequence common to all RUNX family members). Luciferase reporter assay of GSTA2 promoter and chromatin immunoprecipitation (ChIP) assay in the proximal promoter region of GSTA2 gene proved the association of RUNX family members with this genomic region. These results indicated that total amount of RUNX family expressions modulate the expression of GSTA2 in AML cells, which might results in a paradoxical outbursts of RUNX1 moderately-inhibited AML cells. Since GSTA2 catabolizes and scavenges free radicals such as hydrogen peroxide (H2O2), and decreased intracellular free radicals promote acceleration of cell cycle progression, we next measured the intracellular accumulation of H2O2 in RUNX1 inhibited AML cells. As we have expected, intracellular amount of H2O2 was decreased in sh_Rx1_moderate-transduced AML cells and increased in AML cells transduced with sh_Rx1_profound. Additive transduction of sh_RNAs targeting GSTA2 to AML cells with sh_Rx1_moderate reverted the proliferation speed to the control level, underpinning that growth advantage of moderate RUNX1 inhibition could be attributed to the GSTA2 overexpressions. Taken together, these findings indicate that moderately attenuated RUNX1 expressions paradoxically enhance leukemogenesis in AML cells through intracellular environmental change via GSTA2, which could be a novel therapeutic target in anti-leukemia strategy. Disclosures No relevant conflicts of interest to declare.

scholarly journals miR-431-5p regulates cell proliferation and apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis by targeting XIAP

2020 ◽  
Author(s):  
Yuejiao Wang ◽  
Kailin Zhang ◽  
Xiaowei Yuan ◽  
Neili Xu ◽  
Shuai Zhao ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cell Cycle ◽  
Cell Proliferation ◽  
Real Time ◽  
Cell Cycle Progression ◽  
Cycle Progression ◽  
Proliferation And Apoptosis ◽  
Synovial Tissues ◽  
Proliferation Assays ◽  
Fibroblast Like Synoviocytes

Abstract Background miR-431-5p is dysregulated in various cancers and plays an important function in the development of cancer. However, its role in fibroblast-like synoviocytes (FLSs) in patients with rheumatoid arthritis (RA) remains to be understood.Methods Quantitative real-time polymerase chain reaction was used to detect the relative expression of miR-431-5p in synovial tissues and FLSs. Cell proliferation assays helped examine RA FLS proliferation. Flow cytometry was performed to determine apoptosis and cell cycle progression in RA FLSs. We used dual-luciferase assays to determine the correlation between miR-431-5p and its putative target, X-linked inhibitor of apoptosis (XIAP). Quantitative real-time PCR and western blotting were used to measure XIAP levels in synovial tissues and transfected RA FLSs.Results miR-431-5p was downregulated in synovial tissues and FLSs of patients with RA. Upregulation of miR-431-5p prohibited cell proliferation and the G0/G1-to-S phase transition, but promoted apoptosis in RA FLSs; while miR-431-5p inhibition showed the opposite results. miR-431-5p directly targeted XIAP in RA FLSs, and reversely correlated with XIAP levels in synovial tissues. Notably, XIAP silencing partially restored the effects of miR-431-5p inhibition in RA FLSs.Conclusion miR-431-5p regulates cell proliferation, apoptosis，and cell cycle of RA FLSs by targeting XIAP, suggesting its potential in the treatment of RA.

COX-2 expression and cell cycle progression in human fibroblasts

2001 ◽  
Vol 281 (1) ◽  
pp. C188-C194 ◽  
Author(s):  
Derek W. Gilroy ◽  
Michael A. Saunders ◽  
Kenneth K. Wu
Keyword(s):  
Cell Cycle ◽  
Cell Cycle Progression ◽  
Cellular Proliferation ◽  
Human Fibroblasts ◽  
S Phase ◽  
Prostaglandin E ◽  
Cycle Progression ◽  
Proliferation And Apoptosis ◽  
Serum Inhibition ◽  
Cox 2

Cyclooxygenase-2 (COX-2) is continuously expressed in most cancerous cells where it appears to modulate cellular proliferation and apoptosis. However, little is known about the contribution of transient COX-2 induction to cell cycle progression or programmed cell death in primary cells. In this study we determined whether COX-2 regulates proliferation or apoptosis in human fibroblasts. COX-2 mRNA, protein, and prostaglandin E2(PGE2) were not detected in quiescent cells but were expressed during the G0/G1 phase of the cell cycle induced by serum. Inhibition of COX-2 did not alter G0/G1 to S phase transition or induce apoptosis at concentrations that diminished PGE2. Addition of interleukin-1β to serum enhanced COX-2 expression and PGE2 synthesis over that by serum alone but had no effect on the progression of these cells into S phase. Furthermore, platelet-derived growth factor drove the G0 fibroblasts into the cell cycle without inducing detectable levels of COX-2 or PGE2. Collectively, these data show that transient COX-2 expression in primary human fibroblasts does not influence cell cycle progression.

Pivotal Role of FoxO3 and mTORC1 in the Opposite Effects of SDF-1 and TGF-β on Cell Cycle Progression in CD34+ Stem/Progenitor Cells.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 3363-3363
Author(s):  
Aurelie Chabanon ◽  
Christophe Desterke ◽  
Emilie Rodenburger ◽  
Denis Clay ◽  
Bernadette Guerton ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Stem Cell ◽  
Cell Cycle Progression ◽  
Opposite Effect ◽  
Pivotal Role ◽  
Cycle Progression ◽  
Cd34 Cells ◽  
Cell Cycling ◽  
Cell Niche

Abstract Control of cell cycling is a key process in stem cell fate. A balance between cell quiescence and proliferation within the stem cell niche in interaction with microenvironment is critical for sustaining long-term hematopoiesis and for protection against stress. Among growth factors regulating haematopoietic stem/progenitor cell (HSC/HP) cell cycling, TGF-β is known to be a major negative regulator by blocking cell cycle progression during the G1 phase. Besides its effect on HSC/PH and lymphocyte trafficking, the SDF-1/CXCL12 chemokine is another key regulator which helps maintaining hematopoiesis homeostasis. We have previous demonstrated that SDF-1 acts as a survival and cell cycle promoting factor for CD34+ HSC/HP by triggering the G0-G1 transition and then regulating early cell cycle phases suggesting that it may act as an antagonist of TGF-β on cell cycle progression (Lataillade et al., Blood 2000 and 2002). The general aim of this study was to investigate the mechanisms of this antagonist effect on cell cycle. This work was performed on CD34+ cells purified from the peripheral blood of healthy un-mobilized donors. Since they are mainly in G0, they allow dissecting the early cell cycle phases including the G0-G1 transition. We demonstrated that SDF-1 and TGF-β exert an opposite effect on the expression of cell cycle key regulators such as cyclins and CDKI. We showed that cross-talk between SDF-1 and TGF-β signaling pathways involving PI3K/Akt phosphorylation participates in the control of CD34+ cell cycling. We demonstrated a pivotal role of FoxO3 and mTOR in the TGF-β/SDF-1 control of the quiescence/cycling of hematopoietic progenitors. A model integrating a pivotal role for the activation of two Akt substrates, FoxO3 and mTORC1, in the control of CD34+ cells quiescence/cycling by TGF-β and SDF-1 is proposed. Altogether, our results shed new light on the intracellular signaling mechanisms of SDF-1 and of its implication, together with TGF-β, in cell cycle promotion in primary CD34+ cells. Regarding their opposite effect on cell cycle and survival, we suggest that SDF-1 and TGF-β can be considered as natural mutual competitors, both acting as organizers of the stem cell niche where a balance between HSC hibernation and activation is an essential part of the stemness control.

Sign in / Sign up

Export Citation Format

Share Document